Prosecution Insights
Last updated: October 02, 2026

Teikyo University

Technology areas: Biotechnology & Pharmaceuticals • Semiconductors, Circuits & Optics

6 pending office actions • 4 art units • 6 examiners • 0 of 6 (0%) have an AI response strategy ready

Analysis

Teikyo University is managing 6 pending office actions within the Semiconductors, Circuits & Optics technology area. These actions are distributed among 6 distinct examiners, resulting in a diverse set of perspectives on the university's patent applications. This variety in examiners may require a more tailored approach for each individual application in the portfolio, as no two pending matters are currently assigned to the same person.

The 6 pending office actions are spread across 4 distinct art units, indicating a relatively broad technical reach within the semiconductor field. WRIGHT, ANDREW RUSSELL is the busiest examiner for the university, currently responsible for 1 pending office action. This distribution shows that no single examiner or art unit dominates the university's current prosecution landscape. The presence of 4 distinct art units suggests that the university's research spans several specialized subfields within the broader Semiconductors, Circuits & Optics category.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

6
Total Pending OAs
3
Non-Final OAs
2
Final Rejections
1
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
0
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

5
Hard (83%)
0
Medium (0%)
1
Easy (17%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§112 only1 (17%)
Multi-statute (no §101)5 (83%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

2
Life Sciences
33% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
2
Semiconductors
33% of docket
0
Mechanical / Eng
0% of docket
2
Business / Other
33% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

60 h
Manual time on pending OAs
12 h
Time saved (low, 20%)
21 h
Time saved (mid, 35%)
0.5 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
WRIGHT, ANDREW RUSSELL 1 65.5% +41.7%
SHERMAN, STEPHEN G 1 82.2% +16.8%
MONSUR, NASIMA 1 78.5% +26.7%
THOMAS, BRANDI N 1 82.6% +7.8%
KOROTCHKINA, LIOUBOV G 1 29.5% +67.7%
NGUYEN, QUANG 1 38.0% +52.6%

Quick Wins (1)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18852886 BLOOD VESSEL SEGMENT DISCRIMINATION SYSTEM, BLOOD VESSEL SEGMENT DISCRIMINATION METHOD, AND PROGRAM SHERMAN, STEPHEN G —

Hard Cases (5)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.

App #TitleExaminerDue in
17260418 LIPID PARTICLE CONTAINING A-TYPE CpG OLIGODEOXYNUCLEOTIDE NGUYEN, QUANG 88d overdue
18877741 SURGICAL MICROSCOPE SYSTEM, AUXILIARY IMAGING DEVICE, AND SURGICAL FIELD IMAGING METHOD WRIGHT, ANDREW RUSSELL —
18724864 PHOTOVOLTAIC MODULE ABNORMALITY DETERMINATION SYSTEM, PHOTOVOLTAIC MODULE ABNORMALITY DETERMINATION METHOD, AND PROGRAM MONSUR, NASIMA —
18703154 INTRAOCULAR ILLUMINATION DEVICE AND INTRAOCULAR ILLUMINATION ATTACHMENT THOMAS, BRANDI N —
17924704 THERMOSTABLE GLUCOCEREBROSIDASE KOROTCHKINA, LIOUBOV G —

Interview Candidates (5)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.

App #TitleExaminerDue in
17260418 LIPID PARTICLE CONTAINING A-TYPE CpG OLIGODEOXYNUCLEOTIDE NGUYEN, QUANG 88d overdue
18877741 SURGICAL MICROSCOPE SYSTEM, AUXILIARY IMAGING DEVICE, AND SURGICAL FIELD IMAGING METHOD WRIGHT, ANDREW RUSSELL —
18852886 BLOOD VESSEL SEGMENT DISCRIMINATION SYSTEM, BLOOD VESSEL SEGMENT DISCRIMINATION METHOD, AND PROGRAM SHERMAN, STEPHEN G —
18724864 PHOTOVOLTAIC MODULE ABNORMALITY DETERMINATION SYSTEM, PHOTOVOLTAIC MODULE ABNORMALITY DETERMINATION METHOD, AND PROGRAM MONSUR, NASIMA —
17924704 THERMOSTABLE GLUCOCEREBROSIDASE KOROTCHKINA, LIOUBOV G —

Top Art Units

Art UnitApps
2858 1
2872 1
1653 1
1631 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18877741 SURGICAL MICROSCOPE SYSTEM, AUXILIARY IMAGING DEVICE, AND SURGICAL FIELD IMAGING METHOD WRIGHT, ANDREW RUSSELL — §102§103§112 Non-Final OA — Pending Dec 20, 2024
18852886 BLOOD VESSEL SEGMENT DISCRIMINATION SYSTEM, BLOOD VESSEL SEGMENT DISCRIMINATION METHOD, AND PROGRAM SHERMAN, STEPHEN G — §112 Non-Final OA — Pending Sep 30, 2024
18724864 PHOTOVOLTAIC MODULE ABNORMALITY DETERMINATION SYSTEM, PHOTOVOLTAIC MODULE ABNORMALITY DETERMINATION METHOD, AND PROGRAM MONSUR, NASIMA 2858 §102§112 Final Rejection — Pending Jun 27, 2024
18703154 INTRAOCULAR ILLUMINATION DEVICE AND INTRAOCULAR ILLUMINATION ATTACHMENT THOMAS, BRANDI N 2872 §102§103 Final Rejection — Pending Apr 19, 2024
17924704 THERMOSTABLE GLUCOCEREBROSIDASE KOROTCHKINA, LIOUBOV G 1653 §103§112 Non-Final OA — Pending Nov 11, 2022
17260418 LIPID PARTICLE CONTAINING A-TYPE CpG OLIGODEOXYNUCLEOTIDE NGUYEN, QUANG 1631 §102§103 Non-Final OA 88d overdue Pending Jan 14, 2021

Managing Teikyo University's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month